David Niemiec - Templeton Emerging Independent Trustee
| EMF Fund | USD 11.25 0.03 0.27% |
Mr. David W. Niemiec is an Independent Trustee of Templeton Emerging Markets Fund. He was Director of Emeritus Corporation from 1999 to 2010 and OSI Pharmaceuticals, Inc. a pharmaceutical company from 2006 to 2010 . He was Advisor to Saratoga Partners a private equity fund company . He was formerly Managing Director of Saratoga Partners from 1998 to 2001 . He was Director of SBC Warburg Dillon Read an investment banking company from 1997 to 1998. He was Vice Chairman of Dillon Read Co. Inc. an investment banking company from 19911997 . He was also Chief Financial Officer at Dillon Read Co. Inc. from 1982 to 1997 .
| Age | 72 |
| Tenure | 19 years |
| Phone | 65 6241 2662 |
| Web | https://www.franklintempleton.com/en-us-retail/investor/products/other-funds/closed-end-fund-detail.page?FundID=911 |
Templeton Emerging Management Performance (%)
The company has Return on Asset of 0.42 % which means that on every $100 spent on assets, it made $0.42 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (21.58) %, meaning that it generated no profit with money invested by stockholders. Templeton Emerging's management efficiency ratios could be used to measure how well Templeton Emerging manages its routine affairs as well as how well it operates its assets and liabilities.Similar Money Managers
| Showing other executives | One Year Return | ||
| Michael Bonney | Tekla Life Sciences | 59 | |
| James Kirchner | Eaton Vance New | 52 | |
| Cedric Antosiewicz | Nuveen Amt Free Municipal | 57 | |
| Robert Fairbairn | Blackrock Enhanced Capital | 56 | |
| Ronald Pearlman | Eaton Vance New | 76 | |
| James Flynn | Blackrock Enhanced Capital | 79 | |
| Susan Sutherland | Eaton Vance New | 62 | |
| Thomas Faust | Eaton Vance New | 61 | |
| Lagan Srivastava | Pimco New York | 39 | |
| Janey Ahn | Blackrock Enhanced Capital | 46 | |
| Heather Kaden | Cohen Steers Limited | 40 | |
| Frank Gentile | Tekla Healthcare Investors | 62 | |
| Robert Hubbard | Blackrock Enhanced Capital | 63 | |
| David Lamb | Nuveen Mortgage Opportunity | 57 | |
| Jenna Bailey | Western Asset High | 42 | |
| Christopher MBA | Tekla Healthcare Investors | N/A | |
| Cedric Antosiewicz | Nuveen New York | 58 | |
| Lisa Phelan | Cohen Steers Limited | 51 | |
| Harriett Taggart | Eaton Vance New | 70 | |
| Robert Frenkel | Western Asset High | 66 | |
| Kathleen Feldstein | Blackrock Enhanced Capital | 77 | |
Management Performance
| Return On Equity | -21.58 | ||||
| Return On Asset | 0.42 |
Templeton Emerging Leadership Team
Elected by the shareholders, the Templeton Emerging's board of directors comprises two types of representatives: Templeton Emerging inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Templeton. The board's role is to monitor Templeton Emerging's management team and ensure that shareholders' interests are well served. Templeton Emerging's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Templeton Emerging's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Luttig, Independent Trustee | ||
| Robert Kubilis, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| David Niemiec, Independent Trustee | ||
| Robert Lim, Vice President-AML Compliance | ||
| Frank Olson, Independent Trustee | ||
| Manraj Sekhon, President, Chief Executive Officer — Investment Management | ||
| Matthew Hinkle, Chief Executive Officer— Finance and Administration | ||
| Craig Tyle, Vice President Assistant Secretary | ||
| Larry Thompson, Independent Trustee | ||
| Steven Gray, Vice President Assistant Secretary | ||
| Mark Mobius, President CEO - Investment Management | ||
| Aliya Gordon, Vice President Assistant Secretary | ||
| Francis Crothers, Independent Trustee | ||
| Navid Tofigh, Vice President Assistant Secretary | ||
| Bates Torre, Independent Trustee | ||
| Robert Rosselot, Chief Compliance Officer | ||
| Gregory Johnson, Trustee | ||
| Lori Weber, Vice President and Secretary | ||
| Laura Fergerson, Treasurer | ||
| Constantine Tseretopoulos, Independent Trustee | ||
| Edith Holiday, Lead Independent Trustee | ||
| Harris Ashton, Independent Trustee | ||
| Rupert Johnson, Chairman, VP, Director of Franklin Advisers Inc, Director of Franklin Investment Advisory Services Inc, Director of Franklin Resources Inc and Director of Franklin Templeton Distributors Inc | ||
| Breda Beckerle, Chief Compliance Officer | ||
| J Luttig, Independent Trustee | ||
| Susan Kerr, Vice President - AML Compliance | ||
| Selena Holmes, Vice President - AML Compliance | ||
| Karen Skidmore, Vice President Assistant Secretary | ||
| Kimberly Novotny, Vice President Assistant Secretary | ||
| Robert Wade, Independent Trustee | ||
| Mary Choksi, Independent Director | ||
| Christopher Kings, Chief Financial Officer, Chief Accounting Officer, Treasurer | ||
| Mark Otani, CFO, Chief Accounting Officer and Treasurer | ||
| Alison Baur, Vice President Assistant Secretary | ||
| Ann Bates, Independent Trustee |
Templeton Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Templeton Emerging a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -21.58 | ||||
| Return On Asset | 0.42 | ||||
| Operating Margin | 33.81 % | ||||
| Current Valuation | 191.57 M | ||||
| Shares Outstanding | 16.13 M | ||||
| Shares Owned By Institutions | 56.26 % | ||||
| Number Of Shares Shorted | 17.55 K | ||||
| Price To Earning | 4.55 X | ||||
| Price To Book | 0.67 X | ||||
| Price To Sales | 28.94 X |
Pair Trading with Templeton Emerging
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Templeton Emerging position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Templeton Emerging will appreciate offsetting losses from the drop in the long position's value.Moving together with Templeton Fund
| 0.91 | TEI | Templeton Emerging | PairCorr |
| 0.83 | PHK | Pimco High Me | PairCorr |
The ability to find closely correlated positions to Templeton Emerging could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Templeton Emerging when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Templeton Emerging - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Templeton Emerging Markets to buy it.
The correlation of Templeton Emerging is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Templeton Emerging moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Templeton Emerging moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Templeton Emerging can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Templeton Emerging Markets. Also, note that the market value of any fund could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.